SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Naveed Malek, Donald G. Grosset, Medication Adherence in Patients with Parkinson’s Disease, CNS Drugs, 2015, 29, 1, 47

    CrossRef

  2. 2
    Yu-Jung Wei, Francis B. Palumbo, Linda Simoni-Wastila, Lisa M. Shulman, Bruce Stuart, Robert Beardsley, Clayton Brown, Relationships between antiparkinson medication nonadherence, regimen modifications, and healthcare utilization and expenditures, Parkinsonism & Related Disorders, 2015, 21, 1, 36

    CrossRef

  3. 3
    Yu-Jung Wei, Francis B. Palumbo, Linda Simoni-Wastila, Lisa M. Shulman, Bruce Stuart, Robert Beardsley, Clayton H. Brown, Antiparkinson Drug Adherence and Its Association with Health Care Utilization and Economic Outcomes in a Medicare Part D Population, Value in Health, 2014, 17, 2, 196

    CrossRef

  4. 4
    Juan C. Giugni, Michael S. Okun, Treatment of advanced Parkinsonʼs disease, Current Opinion in Neurology, 2014, 27, 4, 450

    CrossRef

  5. 5
    Monika Pötter-Nerger, Peter Ludewig, Ute Hidding, Ines Goerendt, Christian Gerloff, Carsten Buhmann, Wann sind Pflaster, Pens oder Pumpen eine sinnvolle Ergänzung zur oralen Therapie?, InFo Neurologie & Psychiatrie, 2014, 16, 12, 42

    CrossRef

  6. 6
    Jan-Peer Elshoff, Lars Timmermann, Miriam Schmid, Christoph Arth, Michael Komenda, Marcus Brunnert, Lars Bauer, Comparison of the bioavailability and adhesiveness of different rotigotine transdermal patch formulations, Current Medical Research and Opinion, 2013, 29, 12, 1657

    CrossRef

  7. 7
    Wolfgang H. Jost, Late or early treatment in Parkinson's disease?, Basal Ganglia, 2013, 3, 1, 1

    CrossRef

  8. 8
    Jori E. Fleisher, Matthew B. Stern, Medication Nonadherence in Parkinson’s Disease, Current Neurology and Neuroscience Reports, 2013, 13, 10

    CrossRef

  9. 9
    C. Ossig, H. Reichmann, Treatment of Parkinson’s disease in the advanced stage, Journal of Neural Transmission, 2013, 120, 4, 523

    CrossRef

  10. 10
    Diego Santos-García, María Prieto-Formoso, Raúl de la Fuente-Fernández, Levodopa dosage determines adherence to long-acting dopamine agonists in Parkinson's disease, Journal of the Neurological Sciences, 2012, 318, 1-2, 90

    CrossRef

  11. 11
    Ullrich Wüllner, Gerd Fuchs, Nicole Reketat, Olaf Randerath, Jan Kassubek, Requirements for Parkinson’s disease pharmacotherapy from the patients’ perspective: a questionnaire-based survey, Current Medical Research and Opinion, 2012, 28, 7, 1239

    CrossRef

  12. 12
    David James Daley, Phyo Kyaw Myint, Richard John Gray, Katherine Helen O'Leary Deane, Systematic review on factors associated with medication non-adherence in Parkinson's disease, Parkinsonism & Related Disorders, 2012, 18, 10, 1053

    CrossRef

  13. 13
    Robert A. Hauser, Heinz Reichmann, Mark Lew, Afsaneh Asgharian, Clare Makumi, Kenneth J. Shulman, Long-term, Open-label Study of Once-daily Ropinirole Prolonged Release in Early Parkinson's Disease*, International Journal of Neuroscience, 2011, 121, 5, 246

    CrossRef

  14. 14
    F. Valldeoriola, C. Coronell, C. Pont, M. T. Buongiorno, A. Cámara, C. Gaig, Y. Compta, Socio-demographic and clinical factors influencing the adherence to treatment in Parkinson’s disease: the ADHESON study, European Journal of Neurology, 2011, 18, 7
  15. 15
    David J Daley, Katherine HO Deane, Richard J Gray, Paul F Worth, Allan B Clark, Kanagasabesan Sabanathan, Michael Pfeil, Phyo K Myint, The use of carer assisted adherence therapy for people with Parkinson's disease and their carers (CAAT-PARK): study protocol for a randomised controlled trial, Trials, 2011, 12, 1, 251

    CrossRef

  16. 16
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  17. 17
    Marcy L. Tarrants, Michel F. Denarié, Jane Castelli-Haley, Jennifer Millard, Dongmu Zhang, Drug therapies for Parkinson's disease: A database analysis of patient compliance and persistence, The American Journal of Geriatric Pharmacotherapy, 2010, 8, 4, 374

    CrossRef

  18. 18
    Stephen Buetow, Jenny Henshaw, Linda Bryant, Deirdre O'Sullivan, Medication Timing Errors for Parkinson's Disease: Perspectives Held by Caregivers and People with Parkinson's in New Zealand, Parkinson's Disease, 2010, 2010, 1

    CrossRef

  19. 19
    Keith L. Davis, Heather M. Edin, Jeffery K. Allen, Prevalence and cost of medication nonadherence in Parkinson's disease: Evidence from administrative claims data, Movement Disorders, 2010, 25, 4
  20. 20
    Huybert Groenendaal, Marcy L. Tarrants, Christophe Armand, Treatment of Advanced Parkinsonʼs Disease in the United States, Clinical Drug Investigation, 2010, 30, 11, 789

    CrossRef

  21. 21
    Yu-Jung Jenny Wei, Bruce Stuart, Ilene H. Zuckerman, Use of antiparkinson medications among elderly Medicare beneficiaries with Parkinson's disease, The American Journal of Geriatric Pharmacotherapy, 2010, 8, 4, 384

    CrossRef

  22. 22
    F. Valldeoriola, S. Cobaleda, J. Lahuerta, A multicentre retrospective study of the clinical use of ropinirole in the treatment of Parkinson's disease: The ROPI-PARK Study, Clinical Neurology and Neurosurgery, 2009, 111, 9, 742

    CrossRef

  23. 23
    Donald Grosset, Angelo Antonini, Margherita Canesi, Gianni Pezzoli, Andrew Lees, Karen Shaw, Esther Cubo, Pablo Martinez-Martin, Olivier Rascol, Laurence Negre-Pages, Ana Senard, Johannes Schwarz, Karl Strecker, Heinz Reichmann, Alexander Storch, Matthias Löhle, Fabrizio Stocchi, Katherine Grosset, Adherence to antiparkinson medication in a multicenter European study, Movement Disorders, 2009, 24, 6
  24. 24
    Ranjani Manjunath, Keith L. Davis, Sean D. Candrilli, Alan B. Ettinger, Association of antiepileptic drug nonadherence with risk of seizures in adults with epilepsy, Epilepsy & Behavior, 2009, 14, 2, 372

    CrossRef

  25. 25
    Jacquelyn L Bainbridge, J Mark Ruscin, Challenges of Treatment Adherence in Older Patients with Parkinson’s Disease, Drugs & Aging, 2009, 26, 2, 145

    CrossRef

  26. 26
    Maurits E. L. Arbouw, Kris L. L. Movig, Toine C. G. Egberts, Petra J. E. Poels, Jeroen P. P. van Vugt, Judith A. M. Wessels, R. J. H. M. van der Straaten, Cees Neef, Henk-Jan Guchelaar, Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson’s disease, European Journal of Clinical Pharmacology, 2009, 65, 12, 1245

    CrossRef

  27. 27
    Alan B. Ettinger, Ranjani Manjunath, Sean D. Candrilli, Keith L. Davis, Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy, Epilepsy & Behavior, 2009, 14, 2, 324

    CrossRef

  28. 28
    Stephen M. Setter, Assessing the Impact of Ease of Administration and Tolerability on Treatment Choices in Parkinson's Disease, Neurologic Clinics, 2008, 26, 3, 45

    CrossRef

  29. 29
    Carmel M Hughes, Compliance with Medication in Nursing Homes for Older People, Drugs & Aging, 2008, 25, 6, 445

    CrossRef

  30. 30
    Maurits E. L. Arbouw, Kris L. L. Movig, Henk-Jan Guchelaar, Petra J. E. Poels, Jeroen P. P. van Vugt, Cees Neef, Toine C. G. Egberts, Discontinuation of ropinirole and pramipexole in patients with Parkinson’s disease: clinical practice versus clinical trials, European Journal of Clinical Pharmacology, 2008, 64, 10, 1021

    CrossRef

  31. 31
    Peter A. LeWitt, Levodopa for the Treatment of Parkinson's Disease, New England Journal of Medicine, 2008, 359, 23, 2468

    CrossRef

  32. 32
    Amit S. Kulkarni, Rajesh Balkrishnan, Roger T. Anderson, Heather M. Edin, Jeff Kirsch, Mark A. Stacy, Medication adherence and associated outcomes in medicare health maintenance organization-enrolled older adults with Parkinson's disease, Movement Disorders, 2008, 23, 3
  33. 33
    Keith L. Davis, Sean D. Candrilli, Heather M. Edin, Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population, Epilepsia, 2008, 49, 3
  34. 34
    Frances M. Palmieri, Debra L. Barton, Challenges of Oral Medications in Patients With Advanced Breast Cancer, Seminars in Oncology Nursing, 2007, 23, S17

    CrossRef

  35. 35
    Werner H Poewe, Olivier Rascol, Niall Quinn, Eduardo Tolosa, Wolfgang H Oertel, Emilia Martignoni, Markus Rupp, Babak Boroojerdi, Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial, The Lancet Neurology, 2007, 6, 6, 513

    CrossRef

  36. 36
    F. Grandas, B. Hernández, Long-term effectiveness and quality of life improvement in entacapone-treated Parkinson's disease patients: the effects of an early therapeutic intervention, European Journal of Neurology, 2007, 14, 3
  37. 37
    W. T. NG, R. Caslake, C. E Counsell, Non-completion of changes to prescribed medications in people with Parkinson's disease, Age and Ageing, 2007, 36, 3, 333

    CrossRef

  38. 38
    Laser Literature Watch, Photomedicine and Laser Surgery, 2006, 24, 2, 222

    CrossRef

  39. 39
    John L. Goudreau, Medical Management of Advanced Parkinson's Disease, Clinics in Geriatric Medicine, 2006, 22, 4, 753

    CrossRef

  40. 40
    Fabrizio Stocchi, The levodopa wearing-off phenomenon in Parkinson’s disease: pharmacokinetic considerations, Expert Opinion on Pharmacotherapy, 2006, 7, 10, 1399

    CrossRef

  41. 41
    Alan Diamond, Joseph Jankovic, Treatment of advanced Parkinson’s disease, Expert Review of Neurotherapeutics, 2006, 6, 8, 1181

    CrossRef